Quantifying risks and interventions that have affected the burden of diarrhoea among children younger than 5 years: an analysis of the Global Burden of Disease Study 2017 CE Troeger, IA Khalil, BF Blacker, MH Biehl, SB Albertson, SRM Zimsen, ... The Lancet Infectious Diseases 20 (1), 37-59, 2020 | 161 | 2020 |
Funding and services needed to achieve universal health coverage: applications of global, regional, and national estimates of utilisation of outpatient visits and inpatient … MW Moses, P Pedroza, R Baral, S Bloom, J Brown, A Chapin, K Compton, ... The Lancet Public Health 4 (1), e49-e73, 2019 | 96 | 2019 |
Indirect rotavirus vaccine effectiveness for the prevention of rotavirus hospitalization: a systematic review and meta-analysis KL Rosettie, T Vos, AH Mokdad, AD Flaxman, I Khalil, C Troeger, ... The American journal of tropical medicine and hygiene 98 (4), 1197, 2018 | 34 | 2018 |
Comparative risk assessment of school food environment policies and childhood diets, childhood obesity, and future cardiometabolic mortality in the United States KL Rosettie, R Micha, F Cudhea, JL Penalvo, M O’Flaherty, ... PLoS One 13 (7), e0200378, 2018 | 29 | 2018 |
Cost-effectiveness of HPV vaccination in 195 countries: A meta-regression analysis KL Rosettie, JN Joffe, GW Sparks, A Aravkin, S Chen, K Compton, ... PLoS One 16 (12), e0260808, 2021 | 25 | 2021 |
The HIV cure research agenda: the role of mathematical modelling and cost-effectiveness analysis KA Freedberg, C Possas, S Deeks, AL Ross, KL Rosettie, M Di Mascio, ... Journal of virus eradication 1 (4), 245-249, 2015 | 19 | 2015 |
Priority interventions to improve maternal and child diets in S ub‐S aharan A frica and S outh A sia WA Masters, K Rosettie, S Kranz, SH Pedersen, P Webb, G Danaei, ... Maternal & child nutrition 14 (2), e12526, 2018 | 17 | 2018 |
Designing programs to improve diets for maternal and child health: estimating costs and potential dietary impacts of nutrition-sensitive programs in Ethiopia, Nigeria, and India WA Masters, KL Rosettie, S Kranz, G Danaei, P Webb, D Mozaffarian Health policy and planning 33 (4), 564-573, 2018 | 15 | 2018 |
Modelling the potential cost-effectiveness of food-based programs to reduce malnutrition P Webb, G Danaei, WA Masters, KL Rosettie, AA Leech, J Cohen, ... Global food security 29, 100550, 2021 | 14 | 2021 |
The value of point-of-care CD4+ and laboratory viral load in tailoring antiretroviral therapy monitoring strategies to resource limitations EP Hyle, IV Jani, KL Rosettie, R Wood, B Osher, S Resch, PP Pei, ... Aids 31 (15), 2135-2145, 2017 | 13 | 2017 |
Cost-effectiveness of rotavirus vaccination in children under five years of age in 195 countries: A meta-regression analysis MM Janko, J Joffe, D Michael, L Earl, KL Rosettie, GW Sparks, ... Vaccine 40 (28), 3903-3917, 2022 | 8 | 2022 |
Cost-effectiveness of axicabtagene ciloleucel for adult patients with relapsed or refractory follicular lymphoma in the United States OO Oluwole, MD Ray, KL Rosettie, G Ball, J Jacob, SP Bilir, AR Patel, ... Value in Health, 2024 | 1 | 2024 |
Estimating Long-Term Survival Outcomes for Tumor-Agnostic Therapies: Larotrectinib Case Study A Briggs, N Paracha, K Rosettie, A Upton, C Bokemeyer, U Lassen, ... Oncology 100 (2), 124-130, 2022 | 1 | 2022 |
COST-EFFECTIVENESS OF ATEZOLIZUMAB MONOTHERAPY VERSUS PEMBROLIZUMAB MONOTHERAPY FOR FIRST-LINE TREATMENT OF METASTATIC NON-SMALL CELL LUNG CANCER CW Lin, K Rosettie, SP Bilir, H Celik, S Abogunrin, S Ogale VALUE IN HEALTH 24, S37-S37, 2021 | 1 | 2021 |
Cost-effectiveness of atezolizumab monotherapy versus pembrolizumab monotherapy for first-line (1L) treatment of metastatic non-small cell lung cancer (mNSCLC). CW Lin, K Rosettie, P Bilir, H Celik, S Abogunrin, S Ogale Journal of Clinical Oncology 39 (15_suppl), e18847-e18847, 2021 | 1 | 2021 |
Como assumir compromissos SMART de ação em prol da nutrição: Relatório sobre a nutrição mundial nota de orientação J Fanzo, C Hawkes, K Rosettie Intl Food Policy Res Inst, 2016 | 1 | 2016 |
EE197 The Impact of Funding Tocilizumab for the Inpatient Treatment of COVID-19 in the United States: A Distributional Cost-Effectiveness Analysis KL Rosettie, J Best, S Kowal Value in Health 27 (6), S93, 2024 | | 2024 |
EE346 Expanding Cost-Effectiveness Analysis to Demonstrate Population-Level Treatment Impact on Patients and Society FEI Moustaid, KL Rosettie Value in Health 27 (6), S121, 2024 | | 2024 |
MSR8 Validating the Time-Use Algorithm To Estimate Productivity Loss in Persons With Multiple Sclerosis J Fox, ES Mearns, T Majda, KL Rosettie, N Win, S Kowal Value in Health 27 (6), S260-S261, 2024 | | 2024 |
EE469 Societal Costs of Alzheimer's Disease: Informal Caregiver Burden and Patient Productivity Loss J Fox, ES Mearns, KL Rosettie, T Majda, J Li, D Glazebrook, N Win, ... Value in Health 27 (6), S143, 2024 | | 2024 |